» Authors » Yavuz Havlucu

Yavuz Havlucu

Explore the profile of Yavuz Havlucu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 140
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Celebi Sozener Z, Oguzulgen I, Ozalp Ates F, Baccioglu A, Argun Baris S, Ediger D, et al.
J Asthma . 2025 Feb; :1-11. PMID: 39932533
Objective: The obese-asthma phenotype has gradually increased in the last few years. We aimed to assess the differences between obese and non-obese patients with asthma. Methods: This research is a...
2.
Arslan B, Turk M, Hayme S, Aydin O, Gokmen D, Koycu Buhari G, et al.
Clin Transl Allergy . 2025 Jan; 15(1):e70018. PMID: 39865387
Background: Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma-related death. Objective:...
3.
Beyaz S, Erdinc M, Hayme S, Aslan A, Aydin O, Gokmen D, et al.
Allergol Immunopathol (Madr) . 2025 Jan; 53(1):12-25. PMID: 39786871
Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in asthma management remain limited. This...
4.
Simsek S, Kizilirmak D, Havlucu Y
Tuberk Toraks . 2025 Jan; 72(4):268-279. PMID: 39745226
Introduction: Telemedicine is a health service that provides diagnosis, treatment evaluation, preventive medicine by using information and communication technologies between distant locations and aims to improve the health of the...
5.
Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen I, Soyyigit S, et al.
Respir Med . 2024 Dec; 236:107883. PMID: 39617354
Current guidelines recommend adding long-acting muscarinic antagonists (LAMAs) in patients with uncontrolled asthma, despite the use of moderate to high doses of inhaled steroid-long-acting beta agonists (ICS/LABA). This study aims...
6.
Avci I, Celik P, Kizilirmak D, Havlucu Y
Bratisl Lek Listy . 2024 Jul; 125(9):580-586. PMID: 38989764
Objective: The aim of the study is to evaluate the functional status and quality of life parameters of patients in the 1st and 6th months post-COVID and to determine contributing...
7.
Kizilirmak D, Fidan U, Havlucu Y
Tuberk Toraks . 2024 Jun; 72(2):114-119. PMID: 38869203
Introduction: Cancer-related venous thromboembolism is one of the leading causes of mortality and morbidity in cancer patients. Lung cancer is the second most common cancer in the world and is...
8.
Damadoglu E, Aktas O, Gemicioglu B, Yilmaz N, Bozkus F, Ayhan V, et al.
Turk J Med Sci . 2024 May; 54(1):309-315. PMID: 38812643
Background/aim: Characteristics of asthma in the elderly population is not well-known. The aim of the present study was to evaluate asthma in the elderly population, to compare disease characteristics between...
9.
Celik G, Aydin O, Sen E, Demir T, Gemicioglu B, Kiyan E, et al.
Tuberk Toraks . 2024 Apr; 72(1):25-36. PMID: 38676592
Introduction: Patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) have a greater disease burden than those with COPD or asthma alone. In this study, it was aimed to determine...
10.
Kizilirmak D, Havlucu Y
Cureus . 2023 Nov; 15(10):e47187. PMID: 38021834
Introduction: Stenotrophomonas maltophilia infection is gaining importance as an important cause of nosocomial pneumonia. S. maltophilia infection occurs especially in patients with a history of immunosuppression, comorbidity, or multiple antibiotherapy...